Experimental Tongue Therapy Helps Restore Brain Function

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Experimental Tongue Therapy Helps Restore Brain Function

Postby zen2010 » Sat Aug 18, 2018 12:41 am

Hello,

Have you heard about this?
https://www.youtube.com/watch?reload=9&v=ZcLfHA4n0Tc

Cheers
User avatar
zen2010
Family Elder
 
Posts: 137
Joined: Mon Mar 15, 2010 4:00 pm
Location: Villeurbanne, France

Advertisement

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Sat Aug 18, 2018 1:27 am

zen2010 wrote:Hello,

Have you heard about this?
https://www.youtube.com/watch?reload=9&v=ZcLfHA4n0Tc

Cheers


See my post on Norman Doidge's book "The Brain's Way of Healing"

reading-nook-f18/topic28843.html
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Sat Aug 18, 2018 4:51 am

According to Norman Doidge's FAQ, http://www.normandoidge.com/?page_id=1052, the PoNS device is being developed by Helius Medical Technologies http://www.heliusmedical.com/.

Unfortunately, Mozilla is giving me a security error and won't open the page.

Their Twitter page has a photo of the current iteration of the device and a link to a press release.

https://twitter.com/HeliusMedical/media

http://www.heliusmedical.com/press-rele ... r-pons-4-0

Another view of the PoNS is on Instagram.

https://www.instagram.com/p/9wCLzhRjGL/ ... y=ximedica
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Sat Aug 18, 2018 7:55 pm

The PoNS device is being manufactured by Key Tronic Corporation in Oakdale, Minnesota.

http://www.globenewswire.com/news-relea ... rtner.html
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Sun Aug 19, 2018 2:18 am

More info from a Helius Medical investor presentation.

https://www.youtube.com/watch?v=XVRChbVsf8Y
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Fri Aug 24, 2018 1:06 am

NHE wrote:...the PoNS device is being developed by Helius Medical Technologies

Their Twitter page has a photo of the current iteration of the device and a link to a press release.

https://twitter.com/HeliusMedical/media

Another view of the PoNS is on Instagram.

https://www.instagram.com/p/9wCLzhRjGL/ ... y=ximedica

The current iteration of the device was developed by Ximedica.

http://www.ximedica.com/solutions/cases ... erapeutics

The statement that they had to meet "...the challenge of designing a GUI that met the cognitive requirements of the user population." is a little insulting though. The prototype only had 4 buttons and a couple of LEDs. How complex was that?
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby jimmylegs » Fri Aug 24, 2018 5:56 am

thin academic footing

n=1:

A novel neuromodulation technique for the rehabilitation of balance and gait: A case study (2018)
https://www.jocn-journal.com/article/S0 ... 3/abstract
"...
•CN-NINM was used during physiotherapy for the rehabilitation of gait and balance.
•In this patient, gait and balance improved in all tests and without adverse effects.
•This is the first case other than in MS and stroke using CN-NINM for rehabilitation
...To deliver the non-invasive neuromodulation we used a Portable Neuromodulation Stimulation (PoNS™) device (Helius Medical Technologies)"

haven't read full text but would be interesting to see whether or how they attempt to deal with confounders

n = 14:

Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging study (2017)
http://journals.sagepub.com/doi/abs/10. ... 7317690561
"The objective of this paper is to study effects of noninvasive tongue stimulation using the Portable Neuromodulation Stimulator (PoNS™) combined with intensive cognitive and physical rehabilitation on working memory, gait, balance and concomitant changes in the brain.

................................active............sham
MS duration (years)........11.2.............22.3
Age range (yrs)...........28–61..........38–62
Disease duration for the sham group is significantly longer (F = 5.109, p ≤ 0.045)....


Active group members adjusted the PoNS stimulus until felt as a moderately intense tingling sensation. The sham device required no stimulus adjustment...

hmm not fishy design at all :confused: key point wrt neuroplasticity: "age distribution of active group significantly wider/younger"

...The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was sponsored by Helius Medical Technologies Inc under a contract with McGill University and the Clinical Research Unit at the Montreal Neurological Institute."

removing trademarked terms from the scholar search:

n=20:

Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial (2014)
full text https://jneuroengrehab.biomedcentral.co ... 0003-11-79
"Both groups completed a 14-week intervention program using a standardized combination of exercise and a device that provided electrical stimulation to the tongue. Those in the active group received electrical stimulation on the tongue that they could perceive. Those in the control group used a device that did not provide a physiologically significant stimulus and was not perceivable."

not sure what i think about the sham
"From our previous research, we have observed that with experience, subjects set the intensity level at between 50 and 80% of the maximum dynamic range of sensation [43, 44, 45, 46, 47, 48, 50, 51, 52]. If subjects could not feel it, they were reassured that they were still receiving stimulation but it was below their individual threshold of perception."

yeah i think i would know pretty quickly which arm of the study i was in...

giant bias alert (so much for taking trademarks out of the search terms):
"All authors are affiliated with the University of Wisconsin, Madison.

MT teaches in the Department of Biomedical Engineering at the University of Wisconsin, Madison. He is a co-inventor of the PoNS device and is a contributor to the development of the CN-NINM training method. YD is a co-inventor of the PoNS device and is a major contributor to the development of the CN-NINM training method. KK is an expert in electrotactile stimulation and a co-inventor of the PoNS device."
take control of your own health
pursue optimal self care at least as actively as a diagnosis
ask for referrals to preventive health care specialists eg dietitians
don't let suboptimal self care muddy any underlying diagnostic picture!
User avatar
jimmylegs
Volunteer Moderator
 
Posts: 11584
Joined: Sat Mar 11, 2006 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Wed Sep 05, 2018 2:49 am

Helius Medical Technologies Submits Request for FDA 510(k) Clearance of the PoNS™ Device
September 04, 2018: 07:00 AM ET

https://money.cnn.com/news/newsfeeds/ar ... 372059.htm

NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the Company has submitted a request to the U.S. Food and Drug Administration (“FDA”) for de novo classification and 510(k) clearance of the Portable Neuromodulation Stimulator (PoNS™) device.

“Helius is excited to announce the submission of our request for de novo classification and 501(k) clearance of the PoNS device for the treatment of chronic balance deficit due to mild- to moderate-traumatic brain injury,” said Philippe Deschamps, Helius’ President, CEO and Chairman. “This important milestone is the result of many years of hard work from the Helius team, and it brings us one step closer to making our novel PoNS Treatment available for U.S. patients who suffer from the potentially disabling effects of TBI-related chronic balance disorder.”

The Company’s request for de novo classification and 510(k) clearance is supported by clinical data from two double-blind, randomized, controlled trials demonstrating the PoNS device’s safety and efficacy, with combined enrollment of 163 patients. It is also informed by feedback provided by FDA during pre-submission meetings that focused on the Company’s trial designs, clinical data and design verification testing.

Mr. Deschamps continued: “Looking ahead, the Company is focused on laying the groundwork for the commercial launch of our PoNS Treatment following FDA clearance and pursuing regulatory clearances in Canada, Australia, Europe.”
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Wed Sep 05, 2018 3:29 am

NHE wrote:Helius Medical Technologies Submits Request for FDA 510(k) Clearance of the PoNS™ Device
September 04, 2018: 07:00 AM ET

https://money.cnn.com/news/newsfeeds/ar ... 372059.htm

NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the Company has submitted a request to the U.S. Food and Drug Administration (“FDA”) for de novo classification and 510(k) clearance of the Portable Neuromodulation Stimulator (PoNS™) device.


What is the De Novo Classification Process?
https://www.rcri-inc.com/understanding- ... n-process/

The De Novo classification process, also known as “Evaluation of Automatic Class III Designation,” is a device classification process that allows FDA to classify new devices that are not equivalent to an existing Class I or Class II device and would otherwise be automatically classified as a Class III device [Section 513(f)(1 ) of the FD&C Act)], regardless of the device risks or the ability to demonstrate general or special controls.


510(k) Clearance
https://www.drugwatch.com/fda/510k-clearance/

If a company can prove its device is “substantially equivalent” to another already on the market, it can forego clinical trials and testing, saving time and money. Unlike the more rigorous PMA standard, which is to reasonably ensure safety and effectiveness, the 510(k) standard is to determine whether a device is substantially equivalent to a legally marketed device.

In other words, when the FDA clears a device through 510(k), it is not examining if the product is safe or effective for use in patients. It is just agreeing with the maker’s claim that the device is similar to another device already on the market.


Well that's interesting. De novo classification seems to be in conflict with 510(k) clearance. One says there are no similar products on the market and the other says there are. I have read that the PoNS device is the first of it's type. How does 510(k) clearance apply then?
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Wed Sep 05, 2018 4:13 am

Oh, and Helius' company execs have been buying up lots of stock lately. Hmmm... ? 8O

https://money.cnn.com/quote/shareholder ... ?symb=HSDT

Dane C. Andreeff, president of Andreeff Equity Advisors, L.L.C. and on Helius' board of directors, purchased 10,000 shares near the end of June.

Thomas Griffin is also on Helius' board of directors and has purchased 3,346 shares.
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby zen2010 » Thu Sep 06, 2018 1:21 am

NHE wrote:
NHE wrote:Helius Medical Technologies Submits Request for FDA 510(k) Clearance of the PoNS™ Device
September 04, 2018: 07:00 AM ET
https://money.cnn.com/news/newsfeeds/ar ... 372059.htm


Hi,

I don't really know what to think about this... I mean, this should be a very popular topic in the pwms community, but it's not.

Well, time will tell...

If FDA approves this request, US should be the first country to use it. Good Luck!

Do you know how long it takes for the FDA to decide whether a request is accepted or not?

Cheers
User avatar
zen2010
Family Elder
 
Posts: 137
Joined: Mon Mar 15, 2010 4:00 pm
Location: Villeurbanne, France

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Thu Sep 06, 2018 3:08 am

NHE wrote:510(k) Clearance
https://www.drugwatch.com/fda/510k-clearance/

If a company can prove its device is “substantially equivalent” to another already on the market, it can forego clinical trials and testing, saving time and money. Unlike the more rigorous PMA standard, which is to reasonably ensure safety and effectiveness, the 510(k) standard is to determine whether a device is substantially equivalent to a legally marketed device.

In other words, when the FDA clears a device through 510(k), it is not examining if the product is safe or effective for use in patients. It is just agreeing with the maker’s claim that the device is similar to another device already on the market.


Well that's interesting. De novo classification seems to be in conflict with 510(k) clearance. One says there are no similar products on the market and the other says there are. I have read that the PoNS device is the first of it's type. How does 510(k) clearance apply then?


I suppose that they're trying to show that the new model is identical in function to the prototype that was used in the clinical trials though the prototype was never "on the market."
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Thu Sep 06, 2018 3:13 am

zen2010 wrote:I don't really know what to think about this... I mean, this should be a very popular topic in the pwms community, but it's not.

Yes. To see the videos of the positive changes in people's walking is quite remarkable.
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby NHE » Sat Sep 08, 2018 1:53 am

zen2010 wrote:Do you know how long it takes for the FDA to decide whether a request is accepted or not?

The following website claims that the average time for FDA 510(k) clearance is around 6 months.
https://www.emergobyul.com/resources/re ... s-research

De novo classification takes 4 months to determine if a new device is class I or II or remains as class III. All new devices meeting de novo guidelines are automatically designated as class III unless reclassified.
https://www.emergobyul.com/services/uni ... sification

Understanding FDA medical device classification.
https://www.innovatum.com/2014/12/under ... l-devices/

Examples of Class I devices include: elastic bandages, dental floss and enemas.
Class II devices include: condoms, pregnancy testing kits and powered wheelchairs.
Examples of Class III devices include: implantable pacemakers and breast implants.


In a nutshell, we may see the PoNS for retail sale in about 6 months if it's successful. Helius estimates the retail price for the PoNS at $2500.
User avatar
NHE
Volunteer Moderator
 
Posts: 4895
Joined: Sat Nov 20, 2004 4:00 pm

Re: Experimental Tongue Therapy Helps Restore Brain Function

Postby zen2010 » Sat Sep 08, 2018 4:05 am

NHE wrote:The following website claims that the average time for FDA 510(k) clearance is around 6 months.
https://www.emergobyul.com/resources/re ... s-research


From the above website: "The 15,000+ device clearances we analyzed in March 2017"

15,000+ in a month?!?!?
Seriously?That's 500+ per day!
User avatar
zen2010
Family Elder
 
Posts: 137
Joined: Mon Mar 15, 2010 4:00 pm
Location: Villeurbanne, France

Next

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service